HR 9687 · 117th Congress
Medical Innovation Act of 2022
This bill creates a new fee that pharmaceutical companies must pay if they've settled legal cases with the federal government and make blockbuster drugs that benefited from government-funded research. Specifically, it targets large drug manufacturers that have paid settlements for violations like fraud, false claims…
- Sponsor
- Welch, Peter (D-VT)
- Introduced
- 2022-12-22
- Policy area
- Health
- Latest action
- Referred to the House Committee on Energy and Commerce.
Digging through Congress... 🔍